Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma

Por Porta, Camillo, Paglino, Chiara, Mutti, Luciano
Publicado em 2008

Perifosine as a Potential Novel Anti-Cancer Agent Inhibits EGFR/MET-AKT Axis in Malignant Pleural Mesothelioma

Por Pinton, Giulia, Manente, Arcangela Gabriella, Angeli, Giovanni, Mutti, Luciano, Moro, Laura
Publicado em 2012

In vitro and in vivo characterization of highly purified Human Mesothelioma derived cells

Por Zunino Annalisa, Marubbi Daniela, Daga Antonio, Melotti Alice, Mutti Luciano, Corte Giorgio
Publicado em 2010-02-01

In vitro and in vivo characterization of highly purified Human Mesothelioma derived cells

Por Melotti, Alice, Daga, Antonio, Marubbi, Daniela, Zunino, Annalisa, Mutti, Luciano, Corte, Giorgio
Publicado em 2010

PARP1 inhibition affects pleural mesothelioma cell viability and uncouples AKT/mTOR axis via SIRT1

Por Pinton, Giulia, Manente, Arcangela Gabriella, Murer, Bruno, Marino, Elvira, Mutti, Luciano, Moro, Laura
Publicado em 2013

Targeting hypoxic response for cancer therapy

Por Paolicchi, Elisa, Gemignani, Federica, Krstic-Demonacos, Marija, Dedhar, Shoukat, Mutti, Luciano, Landi, Stefano
Publicado no Oncotarget (2016)

Epigallocatechin-3-gallate induces mesothelioma cell death via H(2)O(2)—dependent T-type Ca(2+) channel opening

Por Ranzato, Elia, Martinotti, Simona, Magnelli, Valeria, Murer, Bruno, Biffo, Stefano, Mutti, Luciano, Burlando, Bruno
Publicado em 2012

Switching off malignant mesothelioma: exploiting the hypoxic microenvironment

Por Nabavi, Noushin, Bennewith, Kevin L., Churg, Andrew, Wang, Yuzhuo, Collins, Colin C., Mutti, Luciano
Publicado no Genes Cancer (2016)

Preclinical Demonstration of Synergistic Active Nutrients/Drug (AND) Combination as a Potential Treatment for Malignant Pleural Mesothelioma

Por Volta, Viviana, Ranzato, Elia, Martinotti, Simona, Gallo, Simone, Russo, Maria Veronica, Mutti, Luciano, Biffo, Stefano, Burlando, Bruno
Publicado em 2013

Expression and activity of eIF6 trigger Malignant Pleural Mesothelioma growth in vivo

Por Miluzio, Annarita, Oliveto, Stefania, Pesce, Elisa, Mutti, Luciano, Murer, Bruno, Grosso, Stefano, Ricciardi, Sara, Brina, Daniela, Biffo, Stefano
Publicado no Oncotarget (2015)

Estrogen Receptor β Exerts Tumor Repressive Functions in Human Malignant Pleural Mesothelioma via EGFR Inactivation and Affects Response to Gefitinib

Por Pinton, Giulia, Thomas, Warren, Bellini, Paolo, Manente, Arcangela Gabriella, Favoni, Roberto E., Harvey, Brian J., Mutti, Luciano, Moro, Laura
Publicado em 2010

Preliminary data suggestive of a novel translational approach to mesothelioma treatment: imatinib mesylate with gemcitabine or pemetrexed

Por Bertino, Pietro, Porta, Camillo, Barbone, Dario, Germano, Serena, Busacca, Sara, Pinato, Sabrina, Tassi, Giancarlo, Favoni, Roberto, Gaudino, Giovanni, Mutti, Luciano
Publicado em 2007

SV40 replication in human mesothelial cells induces HGF/Met receptor activation: A model for viral-related carcinogenesis of human malignant mesothelioma

Por Cacciotti, Paola, Libener, Roberta, Betta, Piergiacomo, Martini, Fernanda, Porta, Camillo, Procopio, Antonio, Strizzi, Luigi, Penengo, Lorenza, Tognon, Mauro, Mutti, Luciano, Gaudino, Giovanni
Publicado em 2001

Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells

Por Fiorillo, Marco, Lamb, Rebecca, Tanowitz, Herbert B., Mutti, Luciano, Krstic-Demonacos, Marija, Cappello, Anna Rita, Martinez-Outschoorn, Ubaldo E., Sotgia, Federica, Lisanti, Michael P.
Publicado no Oncotarget (2016)

MSLN Gene Silencing Has an Anti-Malignant Effect on Cell Lines Overexpressing Mesothelin Deriving from Malignant Pleural Mesothelioma

Por Melaiu, Ombretta, Stebbing, Justin, Lombardo, Ylenia, Bracci, Elisa, Uehara, Norihisa, Bonotti, Alessandra, Cristaudo, Alfonso, Foddis, Rudy, Mutti, Luciano, Barale, Roberto, Gemignani, Federica, Giamas, Georgios, Landi, Stefano
Publicado em 2014

Correction: BAK and NOXA Are Critical Determinants of Mitochondrial Apoptosis Induced by Bortezomib in Mesothelioma

Por Busacca, Sara, Chacko, Alex D., Klabatsa, Astero, Arthur, Kenneth, Sheaff, Michael, Barbone, Dario, Mutti, Luciano, Gunasekharan, Vignesh K., Gorski, Julia J., El-Tanani, Mohamed, Broaddus, V. Courtney, Gaudino, Giovanni, Fennell, Dean A.
Publicado em 2013

Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesotheli...

Por Melaiu, Ombretta, Catalano, Calogerina, De Santi, Chiara, Cipollini, Monica, Figlioli, Gisella, Pellè, Lucia, Barone, Elisa, Evangelista, Monica, Guazzelli, Alice, Boldrini, Laura, Sensi, Elisa, Bonotti, Alessandra, Foddis, Rudy, Cristaudo, Alfonso, Mutti, Luciano, Fontanini, Gabriella, Gemignani, Federica, Landi, Stefano
Publicado no Genes Cancer (2017)